Dexamethasone Reduces Postoperative Pain, Opioid and Antiemetic Use in Total Shoulder Arthroplasty .
Dexamethasone decreases postoperative opioid and antiemetic use in shoulder arthroplasty patients: a prospective, randomized controlled trial.
J Shoulder Elbow Surg. 2021 Jul;30(7): 1544-1552.Seventy five patients undergoing anatomic or reverse total shoulder arthroplasty (TSA) were randomized to receive perioperative intravenous dexamethasone (n=43) or no treatment (n=32). The primary outcome of interest was postoperative morphine use over the first 24h postoperatively. Other outcomes of interest included postoperative pain scores, antiemetic use, nausea and vomiting, length of stay and complications. The dexamethasone group demonstrated significantly lower morphine consumption over the first 24h postoperatively. The dexamethasone group also had reduced pain scores at all time points and reduced antiemetic use in the first 4h postoperatively. There was no significant difference in postoperative nausea and vomiting, length of stay or complications.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
